Skip to main content

Table 4 Distribution of reminders by clinical condition and specific reminder in the intervention and control groups

From: Effectiveness of electronic point-of-care reminders versus monthly feedback to improve adherence to 10 clinical recommendations in primary care: a cluster randomized clinical trial

 

Control group reminders

Intervention group reminders

Total reminders

Clinical condition

Type of reminder

No.

%

No.

%

No.

%

Type 2 diabetes mellitus

Screen for diabetic retinopathy

34,748

7.4

36,649

7.5

71,397

7.45

Measure glycated hemoglobin

47,582

10.13

49,873

10.2

97,455

10.17

High blood pressure

Measure blood pressure

22,0382

46.94

23,0559

47.17

45,0941

47.05

Atrial fibrillation

Treat with antiplatelet drug/anticoagulant

4650

0.99

4852

0.99

9502

0.99

Cerebrovascular accident/ischemic heart disease

Measure LDL cholesterol

43,032

9.17

44,196

9.04

87,228

9.1

Treat with antiplatelet drug

9807

2.09

10,489

2.15

20,296

2.12

Heart failure/ischemic heart disease

Treat with beta blocker

32,810

6.99

34,312

7.02

67,122

7

Heart failure

Treat with ACEI/ARB

7189

1.53

7733

1.58

14,922

1.56

Hepatitis C

Hepatitis B vaccine

8681

1.85

8535

1.75

17,216

1.8

Smoking

Encourage smoking cessation

60,633

12.91

61,613

12.6

122,246

12.76

 

Total

469,514

100

488,811

100

958,325

100

  1. Abbreviations: ACEI Angiotensin-converting enzyme inhibitor, ARB Angiotensin II receptor blocker, LDL Low-density lipoprotein